Not applicableStudy completedNCT01008020What this trial is testingEffects of Tea Catechin Consumption on the Prophylaxis of Influenza InfectionWho this might be right forInfluenza Infection Masahiro Morikawa 200
Large-scale testing (Phase 3)Study completedNCT00617318What this trial is testingPomegranate Products for Prevention of Common ColdWho this might be right forInfluenzaCommon ColdCough+2 more Texas Heart Institute 461
Early research (Phase 1)Study completedNCT00922259What this trial is testingSafety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7Who this might be right forInfluenza A National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Study completedNCT05071313What this trial is testingAn Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and OlderWho this might be right forInfluenza, Human PreventionRespiratory Syncytial Viruses Prevention Janssen Vaccines & Prevention B.V. 777
Post-approval studies (Phase 4)Study completedNCT03143101What this trial is testingEvaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of AgeWho this might be right forInfluenzaHealthy MedImmune LLC 200
Large-scale testing (Phase 3)Study completedNCT03699839What this trial is testingReducing the Burden of Influenza After Solid-Organ TransplantationWho this might be right forInfluenzaOrgan Transplantation Oriol Manuel 619
Testing effectiveness (Phase 2)Study completedNCT05507567What this trial is testingSafety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge ModelWho this might be right forInfluenza Viral Infections Pneumagen Ltd. 104
Post-approval studies (Phase 4)Study completedNCT03564444What this trial is testingD2560C00015 FluMist Annual Safety Study 2018Who this might be right forInfluenzaHealthy MedImmune LLC 300
Not applicableLooking for participantsNCT06029933What this trial is testingFluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 YearsWho this might be right forInfluenzaCommunity-acquired PneumoniaCardiovascular Events Kaiser Permanente 1,500,000
Post-approval studies (Phase 4)Study completedNCT02473510What this trial is testingStudy to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 SeasonWho this might be right forInfluenzaHealthy MedImmune LLC 301
Testing effectiveness (Phase 2)Study completedNCT00478816What this trial is testingSafety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza VaccinesWho this might be right forProphylaxis of Avian Influenza Vaccine Novartis Vaccines 58
Post-approval studies (Phase 4)UnknownNCT01053377What this trial is testingA Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing HomesWho this might be right forInfluenza National Institute for Public Health and the Environment (RIVM) 900
Not applicableWithdrawnNCT00844155What this trial is testingStudy of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care UnitWho this might be right forInfluenza A Virus InfectionInfluenza B Virus Infection University of Manitoba
Not applicableStudy completedNCT00778297What this trial is testingImmunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza VaccineWho this might be right forInfluenza Fluart Innovative Vaccine Ltd, Hungary 234
Not applicableStudy completedNCT00306982What this trial is testingIncidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™Who this might be right forInfluenza GlaxoSmithKline 1,524
Early research (Phase 1)Study completedNCT01405885What this trial is testingDNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza VirusWho this might be right forHealthy Inovio Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT06873282What this trial is testingPhase 2 Study of the ТВ/Flu-05Е Tuberculosis VaccineWho this might be right forTuberculosis Research Institute of Influenza, Russia 160
Early research (Phase 1)Study completedNCT00347672What this trial is testingSafety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy AdultsWho this might be right forInfluenzaVirus Diseases National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Ended earlyNCT02883426What this trial is testingEvaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v DiseaseWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 1
Testing effectiveness (Phase 2)Study completedNCT00620815What this trial is testingSafety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and AboveWho this might be right forInfluenza Novartis Vaccines 601